Fierce Pharma: Meeting the commercialization challenge of a surging gene and cell therapy market
FierceBiotech
Undaunted by the challenges the COVID-19 pandemic unleashed on the world the expected surge of cell and gene therapies already in the pipeline and on the horizon will continue to materialize, and with them the complexity of riding that wave of innovation.